BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.
Boccon-Gibod
L
L
Department of Urology, CHU Bichat, Paris, France.
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000628:therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine